Main > GENETICS > Genetic Diseases > Gaucher Disease. > Treatment > Miglustat > Co.: Israel. T (Oral Form./Patents)
Co.: Israel. T (Oral Form./Patents)'s subsections
Company
Licensor
Marketing>Israel
Mechanism:
Patent
Patent>Total USA No.: 2
Patent>UpDate: 12.05.06
Patent>US Expiration: 1012.2014
Status: Approved
Structural Formula
TradeMark
Co.: Israel. T (Oral Form./Patents)'s products
This section has no products